Inflammation

Items 11-20 of 41

per page
Set Descending Direction
  1. anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-1) (Biotin)
    AG-27B-0001B
    AG-27B-0001B-C100100 µg
    CHF 490.00
    Binding of APRIL (mouse) to BCMA is inhibited by anti-APRIL (mouse), mAb (rec.) (blocking) (APRY-1-1) (Prod. No. AG-27B-0001).
BCMA:Fc was coated on an ELISA plate at 1μg /ml. anti-APRIL (mouse) mAb (rec.) (blocking) (APRY-1-1) or an unrelated mA
  2. anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-1) (preservative free)
    AG-27B-0001PF
    AG-27B-0001PF-C100100 µg
    CHF 455.00
    AG-27B-0001PF-C500500 µg
    CHF 1'140.00
    Binding of APRIL (mouse) to BCMA is inhibited by anti-APRIL (mouse), mAb (rec.) (blocking) (APRY-1-1) (Prod. No. AG-27B-0001).
BCMA:Fc was coated on an ELISA plate at 1μg /ml. anti-APRIL (mouse) mAb (rec.) (blocking) (APRY-1-1) or an unrelated mA
  3. anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-3)
    AG-27B-0017
    AG-27B-0017-C100100 µg
    CHF 455.00
  4. anti-BAFF (human), mAb (blocking) (4.62)
    AG-20B-0017
    AG-20B-0017-C100100 µg
    CHF 460.00
  5. anti-BAFF (human), mAb (blocking) (4.62) (Biotin)
    AG-20B-0017B
    AG-20B-0017B-C100100 µg
    CHF 490.00
  6. anti-BAFF (mouse), mAb (blocking) (Sandy-2)
    AG-20B-0063
    AG-20B-0063-C100100 µg
    CHF 470.00
    anti-BAFF (mouse), mAb (Sandy-2) (Prod. No. AG-20B-0063) blocks the action of endogenous BAFF in vivo.  Method: Wild type C57BL/6 mice were treated at day 0 (single administration) with monoclonal antibody anti-BAFF (mouse), mAb (Sandy
  7. anti-BAFF (mouse), mAb (blocking) (Sandy-2) (preservative free)
    AG-20B-0063PF
    AG-20B-0063PF-C100100 µg
    CHF 470.00
    AG-20B-0063PF-C500500 µg
    CHF 1'200.00
    anti-BAFF (mouse), mAb (Sandy-2) (preservative free) (Prod. No. AG-20B-0063PF) blocks the action of endogenous BAFF in vivo.  Method: Wild type C57BL/6 mice were treated at day 0 (single administration) with monoclonal antibody anti-BA
  8. anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
    AG-20B-6001YPF
    AG-20B-6001YPF-C100100 µg
    CHF 290.00
    AG-20B-6001YPF-C500500 µg
    CHF 730.00
    Replaces AG-20B-6001PF
    anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
  9. anti-IL-33 (human), mAb (IL33305B)
    AG-20A-0041
    AG-20A-0041-C05050 µg
    CHF 295.00
    AG-20A-0041-C100100 µg
    CHF 400.00
    Immunohistochemical staining of human tissue using anti-IL-33 (human), mAb (IL33305B) (Prod. No. AG-20A-0041) at 1:100 dilution.A. Immunoperoxidase staining (cytoplasmic) of formalin-fixed, paraffin-embedded human heart (100x, brown colour).B.
  10. anti-IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1)
    AG-27B-0013
    AG-27B-0013-C100100 µg
    CHF 455.00
    Binding of IL-33 (mouse) to ST2 /IL-1RAcp is inhibited by IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) (AG-27B-0013). Methods: IL-33 (mouse) was coated on an ELISA plate at 1μg/ml. IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) (AG-2

Items 11-20 of 41

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.